Adenosine a3 receptor agonists for the treatment of dry eye...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/00 (2006.01) A61K 31/7076 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2622975

The present invention concerns methods and compositions for treating dry eye. The method comprises providing an individual exhibiting ophthalmologic clinical symptoms and signs of dry eye with an A3 adenosine receptor (A3AR) agonist. The A3AR agonist is preferably administered to the subject either topically or orally.

La présente invention concerne des procédés et des compositions de traitement du syndrome de l'AEil sec. Le procédé comprend l'administration d'un agoniste du récepteur A3 de l'adénosine (A3AR) à un individu présentant des symptômes et des signes ophtalmologiques cliniques du syndrome de l'AEil sec. L'agoniste d'A3AR est administré au sujet de préférence par voie locale ou orale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Adenosine a3 receptor agonists for the treatment of dry eye... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenosine a3 receptor agonists for the treatment of dry eye..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a3 receptor agonists for the treatment of dry eye... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1904994

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.